Bioengineered Hydrogels Recapitulate Fibroblast Heterogeneity in Cancer
Source abstract
Abstract
Abstract Recently mapped transcriptomic landscapes reveal the extent of heterogeneity in cancer‐associated fibroblasts (CAFs) beyond previously established single‐gene markers. Functional analyses of individual CAF subsets within the tumor microenvironment are critical to develop more accurate CAF‐targeting therapeutic strategies. However, there is a lack of robust preclinical models that reflect this heterogeneity in vitro. In this study, single‐cell RNA sequencing datasets acquired from head and neck squamous cell carcinoma tissues to predict microenvironmental and cellular features governing individual CAF subsets are leveraged. Some of these features are then incorporated into a tunable hyaluronan‐based hydrogel system to culture patient‐derived CAFs. Control over hydrogel degradability and integrin adhesiveness enabled derivation of the predominant myofibroblastic and inflammatory CAF subsets, as shown through changes in cell morphology and transcriptomic profiles. Last, using these hydrogel‐cultured CAFs, microtubule dynamics are identified, but not actomyosin contractility, as a key mediator of CAF plasticity. The recapitulation of CAF heterogeneity in vitro using defined hydrogels presents unique opportunities for advancing the understanding of CAF biology and evaluation of CAF‐targeting therapeutics.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cancer Cells and Metastasis · Single-cell and spatial transcriptomics · Immune cells in cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Translational Tumor Engineering Laboratory, Department of Biomedical Engineering National University of Singapore Singapore 119276 Singapore
The N.1 Institute for Health National University of Singapore Singapore 117456 Singapore
Cancer Therapeutics Research Laboratory National Cancer Centre Singapore Singapore 168583 Singapore
Duke‐NUS Medical School National University of Singapore Singapore 169857 Singapore
Cancer Science Institute National University of Singapore Singapore 117599 Singapore
References (86)
Show source-provided references
1. 10.1371/journal.pone.015994710.1371/journal.pone.0159947 ↗
2. 10.1038/s43018-022-00411-z10.1038/s43018-022-00411-z ↗
3. 10.3389/fimmu.2019.0183510.3389/fimmu.2019.01835 ↗
4. 10.1016/j.smim.2020.10141710.1016/j.smim.2020.101417 ↗
5. 10.1016/j.ccr.2014.04.00510.1016/j.ccr.2014.04.005 ↗
6. 10.1016/j.ccr.2014.04.02110.1016/j.ccr.2014.04.021 ↗
7. 10.1200/JCO.2015.62.871910.1200/JCO.2015.62.8719 ↗
8. 10.1158/1078-0432.CCR-14-126910.1158/1078-0432.CCR-14-1269 ↗
9. 10.1097/MPA.000000000000045810.1097/MPA.0000000000000458 ↗
10. 10.1038/s41467-018-05220-610.1038/s41467-018-05220-6 ↗
11. 10.1084/jem.2021081510.1084/jem.20210815 ↗
12. 10.1038/s41568-019-0238-110.1038/s41568-019-0238-1 ↗
13. 10.1016/j.actbio.2021.03.03710.1016/j.actbio.2021.03.037 ↗
14. 10.1158/2159-8290.CD-19-138410.1158/2159-8290.CD-19-1384 ↗
15. 10.1084/jem.2016202410.1084/jem.20162024 ↗
16. 10.3858/emm.2009.41.12.09610.3858/emm.2009.41.12.096 ↗
17. 10.1016/j.yexcr.2009.03.00510.1016/j.yexcr.2009.03.005 ↗
18. 10.1016/j.biomaterials.2016.06.06110.1016/j.biomaterials.2016.06.061 ↗
19. 10.1021/acs.langmuir.8b0264910.1021/acs.langmuir.8b02649 ↗
20. 10.1038/s41598-023-38965-210.1038/s41598-023-38965-2 ↗
21. 10.1093/nar/gkh03610.1093/nar/gkh036 ↗
22. 10.1093/nar/gkm88210.1093/nar/gkm882 ↗
23. 10.1093/nar/gkx113210.1093/nar/gkx1132 ↗
24. 10.1002/ctm2.48710.1002/ctm2.487 ↗
25. 10.1158/2159-8290.CD-19-064410.1158/2159-8290.CD-19-0644 ↗
26. 10.1158/2159-8290.CD-19-009410.1158/2159-8290.CD-19-0094 ↗
27. 10.1038/s41467-018-03348-z10.1038/s41467-018-03348-z ↗
28. 10.1038/s41467-023-35832-610.1038/s41467-023-35832-6 ↗
29. 10.1038/s41421-021-00271-410.1038/s41421-021-00271-4 ↗
30. 10.15252/embj.201910406310.15252/embj.2019104063 ↗
31. 10.1016/j.cell.2017.10.04410.1016/j.cell.2017.10.044 ↗
32. 10.1371/journal.pcbi.100922810.1371/journal.pcbi.1009228 ↗
33. 10.1038/s41586-021-03549-510.1038/s41586-021-03549-5 ↗
34. 10.1016/j.tcb.2021.02.00810.1016/j.tcb.2021.02.008 ↗
35. 10.1039/C6IB00093B10.1039/C6IB00093B ↗
36. 10.1038/s41596-020-0336-210.1038/s41596-020-0336-2 ↗
37. 10.1093/bioinformatics/btw21610.1093/bioinformatics/btw216 ↗
38. 10.1186/s12864-018-4772-010.1186/s12864-018-4772-0 ↗
39. 10.1371/journal.pone.010852810.1371/journal.pone.0108528 ↗
40. 10.1158/2159-8290.CD-18-071010.1158/2159-8290.CD-18-0710 ↗
41. 10.1186/s13046-018-0850-z10.1186/s13046-018-0850-z ↗
42. 10.1083/jcb.20050615210.1083/jcb.200506152 ↗
43. 10.1038/cr.2010.17710.1038/cr.2010.177 ↗
44. 10.1038/s41596-020-0292-x10.1038/s41596-020-0292-x ↗
45. 10.1038/s41467-020-18873-z10.1038/s41467-020-18873-z ↗
46. 10.1038/s41587‐023‐01782‐z10.1038/s41587‐023‐01782‐z ↗
47. 10.1021/mp500085p10.1021/mp500085p ↗
48. 10.1016/j.biomaterials.2015.10.05910.1016/j.biomaterials.2015.10.059 ↗
49. 10.1016/j.biomaterials.2022.12152710.1016/j.biomaterials.2022.121527 ↗
50. 10.1016/0092-8674(92)90600-H10.1016/0092-8674(92)90600-H ↗
51. 10.1038/s41587-019-0114-210.1038/s41587-019-0114-2 ↗
52. 10.1038/s41572-020-00224-310.1038/s41572-020-00224-3 ↗
53. 10.1016/j.biomaterials.2023.12246010.1016/j.biomaterials.2023.122460 ↗
54. 10.1016/j.cell.2018.03.02210.1016/j.cell.2018.03.022 ↗
55. 10.1038/s41571-021-00546-510.1038/s41571-021-00546-5 ↗
56. 10.1002/jcp.3004210.1002/jcp.30042 ↗
57. 10.3390/cells1102018510.3390/cells11020185 ↗
58. GlaxoSmithKline. Jemperli (dostarlimab) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI‐H primary advanced or recurrent endometrial cancer https://www.gsk.com/en‐gb/media/press‐releases/jemperli‐plus‐chemotherapy‐approved‐in‐us‐for‐new‐indication/(accessed: July 2023).
59. 10.1016/j.medj.2023.07.00410.1016/j.medj.2023.07.004 ↗
60. R.R Core Team R: A language and environment for statistical computing 2013.
61. Wickham H. · Package ‘ggplot2’ · 2016 · 2 · 1
62. Z.Gu Complexheatmap: Making complex heatmapsR package version 2015 1.
63. J. J.Allaire P.Ellis C.Gandrud K.Kuo B. W.Lewis J.Owen K.Russell J.Rogers C.Sese C. J.Yetman Package ‘networkD3’ D3 JavaScript network graphs from R 2017.
64. M.Nakazawa M. M.Nakazawa Package ‘fmsb’https://cran.r‐project.org/web/packages/fmsb/fmsb.pdf(accessed: January 2019).
65. 10.1093/bioinformatics/btu39310.1093/bioinformatics/btu393 ↗
66. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
67. 10.1038/s41467-023-37379-y10.1038/s41467-023-37379-y ↗
68. 10.1186/s13059-019-1874-110.1186/s13059-019-1874-1 ↗
69. C.Hafemeister R.Satija Analyzing scRNA‐seq data with the sctransform and offset models 2020.
70. 10.1038/s41592-019-0619-010.1038/s41592-019-0619-0 ↗
71. 10.1089/omi.2011.011810.1089/omi.2011.0118 ↗
72. 10.1093/bioinformatics/btr26010.1093/bioinformatics/btr260 ↗
73. 10.1074/mcp.TIR118.00094310.1074/mcp.TIR118.000943 ↗
74. 10.1016/j.cell.2021.04.04810.1016/j.cell.2021.04.048 ↗
75. 10.1038/s41592-019-0667-510.1038/s41592-019-0667-5 ↗
76. 10.1002/jbm.b.3308810.1002/jbm.b.33088 ↗
77. 10.1111/jmi.1230310.1111/jmi.12303 ↗
78. BeatMuench. Xlib. 2021 https://imagej.net/plugins/xlib/(accessed: September 2023).
79. 10.1093/bioinformatics/bts63510.1093/bioinformatics/bts635 ↗
80. 10.1093/nargab/lqaa07810.1093/nargab/lqaa078 ↗
81. 10.1186/s13059-014-0550-810.1186/s13059-014-0550-8 ↗
82. 10.1093/bioinformatics/bty89510.1093/bioinformatics/bty895 ↗
83. 10.1038/s41388-021-01870-x10.1038/s41388-021-01870-x ↗
84. 10.1126/scisignal.200408810.1126/scisignal.2004088 ↗
85. T.Therneau T.Lumley R survival package. R Core Team 2013.
86. A.Kassambara M.Kosinski Package ‘survminer’ Drawing Survival Curves using ‘ggplot2’(R package version 03 1) 2017 3.10.32614/CRAN.package.survminer ↗